VanEck Associates’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1M Sell
76,889
-12,872
-14% -$2.23M 0.01% 552
2026
Q1
$15.2M Buy
89,761
+2,136
+2% +$410K 0.01% 487
2025
Q4
$16.5M Buy
87,625
+6,663
+8% +$1.26M 0.01% 435
2025
Q3
$16.6M Buy
80,962
+1,572
+2% +$336K 0.02% 400
2025
Q2
$17.7M Sell
79,390
-2,109
-3% -$454K 0.02% 350
2025
Q1
$16.8M Buy
81,499
+1,511
+2% +$301K 0.02% 350
2024
Q4
$14.6M Buy
79,988
+1,326
+2% +$279K 0.02% 375
2024
Q3
$16.5M Buy
78,662
+7,798
+11% +$1.5M 0.02% 349
2024
Q2
$12.4M Buy
70,864
+5,140
+8% +$878K 0.02% 369
2024
Q1
$11.3M Buy
65,724
+4,268
+7% +$657K 0.02% 372
2023
Q4
$9.26M Buy
61,456
+5,056
+9% +$678K 0.02% 389
2023
Q3
$6.78M Buy
56,400
+1,880
+3% +$234K 0.01% 426
2023
Q2
$6.78M Buy
54,520
+3,664
+7% +$430K 0.01% 433
2023
Q1
$5.88M Buy
50,856
+2,016
+4% +$222K 0.01% 454
2022
Q4
$5.51M Sell
48,840
-532
-1% -$57.5K 0.01% 441
2022
Q3
$4.79M Buy
49,372
+2,860
+6% +$292K 0.01% 444
2022
Q2
$4.34M Buy
46,512
+784
+2% +$76.4K 0.01% 493
2022
Q1
$4.86M Buy
45,728
+4,488
+11% +$437K 0.01% 510
2021
Q4
$4.57M Buy
41,240
+5,216
+14% +$562K 0.01% 521
2021
Q3
$3.43M Buy
36,024
+3,088
+9% +$302K 0.01% 546
2021
Q2
$3.15M Buy
32,936
+7,388
+29% +$655K 0.01% 552
2021
Q1
$2.18M Buy
25,548
+2,192
+9% +$185K 0.01% 594
2020
Q4
$2.06M Buy
23,356
+1,828
+8% +$159K 0.01% 538
2020
Q3
$1.79M Buy
21,528
+2,476
+13% +$191K 0.01% 518
2020
Q2
$1.27M Buy
19,052
+3,548
+23% +$205K ﹤0.01% 566
2020
Q1
$671K Buy
15,504
+1,416
+10% +$92.5K ﹤0.01% 636
2019
Q4
$948K Buy
+14,088
New +$927K ﹤0.01% 654
2017
Q2
Sell
-4,856
Closed -$154K 766
2017
Q1
$154K Buy
4,856
+364
+8% +$10.8K ﹤0.01% 708
2016
Q4
$130K Buy
4,492
+380
+9% +$10.7K ﹤0.01% 702
2016
Q3
$116K Buy
4,112
+1,080
+36% +$29.6K ﹤0.01% 704
2016
Q2
$74K Buy
3,032
+588
+24% +$13.5K ﹤0.01% 717
2016
Q1
$55K Buy
2,444
+360
+17% +$7.72K ﹤0.01% 722
2015
Q4
$47K Buy
2,084
+484
+30% +$11K ﹤0.01% 681
2015
Q3
$34K Buy
1,600
+208
+15% +$4.46K ﹤0.01% 720
2015
Q2
$29K Buy
+1,392
New +$29.2K ﹤0.01% 742

Other funds holding CTAS

VanEck Associates's CTAS Position: Q2 2026 in Review

VanEck Associates reduced its Cintas (CTAS) stake by 14% in Q2 2026, selling an estimated $2.23M and leaving 76,889 shares worth $13.1M. The position accounts for 0.01% of the portfolio, ranked #552.

VanEck Associates first reported a position in CTAS in Q2 2015 and has held it in 35 quarters since. The position peaked at $17.7M in Q2 2025. 1,420 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • VanEck Associates held 76,889 shares of Cintas worth $13.1M as of Q2 2026.
  • VanEck Associates sold 12,872 Cintas shares in Q2 2026, an estimated $2.23M.
  • Cintas made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #552 holding.
  • VanEck Associates first reported a position in Cintas in Q2 2015 and has held it in 35 quarters since.
  • VanEck Associates's Cintas position peaked at $17.7M in Q2 2025.
  • 1,420 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.